Get the Stockscreener App
4.59
6.25%
0.27
After Hours:
4.59
Trisalus Life Sciences Inc stock is traded at $4.59, with a volume of 158.05K.
It is up +6.25% in the last 24 hours and up +3.61% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$4.32
Open:
$4.33
24h Volume:
158.05K
Relative Volume:
1.53
Market Cap:
$228.89M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-2.6196
EPS:
-1.7522
Net Cash Flow:
-
1W Performance:
-0.86%
1M Performance:
+3.61%
6M Performance:
-16.70%
1Y Performance:
+8.25%
1-Day Range:
$4.19
$4.59
1-Week Range:
$4.19
$4.85
52-Week Range:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.59 | 215.43M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Initiated | Lake Street | Buy |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-11-24 | Initiated | ROTH MKM | Buy |
| Oct-25-24 | Initiated | Northland Capital | Outperform |
| Sep-16-24 | Initiated | Oppenheimer | Outperform |
| May-30-24 | Initiated | Canaccord Genuity | Buy |
View All
Trisalus Life Sciences Inc Stock (TLSI) Latest News
Will TriSalus Life Sciences Inc. Equity Warrant stock recover after recent dropJuly 2025 Reactions & Consistent Return Strategy Ideas - newser.com
What high frequency data says about TriSalus Life Sciences Inc.Gold Moves & AI Driven Stock Movement Reports - newser.com
Tools to monitor TriSalus Life Sciences Inc. recovery probabilityTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Published on: 2025-10-13 09:15:56 - newser.com
Statistical indicators supporting TriSalus Life Sciences Inc. Equity Warrant’s strengthJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
Regression analysis insights on TriSalus Life Sciences Inc. Equity Warrant performanceJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsWeekly Stock Summary & Accurate Buy Signal Alerts - newser.com
Will TriSalus Life Sciences Inc. stock gain from strong economyPortfolio Risk Summary & Fast Moving Trade Plans - newser.com
Will breakout in TriSalus Life Sciences Inc. Equity Warrant lead to full recoveryMarket Movement Recap & Technical Confirmation Alerts - newser.com
Automated trading signals detected on TriSalus Life Sciences Inc. Equity WarrantMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Is it time to cut losses on TriSalus Life Sciences Inc.July 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Published on: 2025-10-10 09:12:22 - newser.com
Will TriSalus Life Sciences Inc. stock deliver strong dividend growthJuly 2025 Weekly Recap & Daily Profit Focused Stock Screening - newser.com
Sentiment analysis tools applied to TriSalus Life Sciences Inc.Quarterly Portfolio Report & Growth Focused Entry Reports - newser.com
TriSalus Life Sciences' (TLSI) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Published on: 2025-10-09 04:25:24 - newser.com
Volume spikes in TriSalus Life Sciences Inc. Equity Warrant stock – what they meanQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
Relative strength of TriSalus Life Sciences Inc. in sector analysisJobs Report & Short-Term Swing Trade Alerts - newser.com
Tick level data insight on TriSalus Life Sciences Inc. volatilityShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
How TriSalus Life Sciences Inc. stock reacts to oil pricesJuly 2025 Outlook & Long-Term Safe Investment Ideas - newser.com
Quantitative breakdown of TriSalus Life Sciences Inc. recent moveMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Will TriSalus Life Sciences Inc. outperform the marketWeekly Trend Report & Consistent Income Trade Ideas - newser.com
Using Bollinger Bands to evaluate TriSalus Life Sciences Inc. Equity Warrant2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Is it too late to sell TriSalus Life Sciences Inc.July 2025 Update & Low Drawdown Trading Techniques - newser.com
How hedge fund analytics apply to TriSalus Life Sciences Inc. Equity Warrant stockJuly 2025 Fed Impact & Low Drawdown Investment Strategies - newser.com
How to build a custom watchlist for TriSalus Life Sciences Inc. Equity WarrantRecession Risk & Trade Opportunity Analysis - newser.com
Tools to monitor TriSalus Life Sciences Inc. Equity Warrant recovery probabilityTrade Analysis Summary & Safe Capital Allocation Plans - newser.com
What analysts say about TriSalus Life Sciences Inc stockHigh Beta Stocks & High Profit Market Tips - earlytimes.in
TriSalus Life Sciences director Sean Murphy resigns from board By Investing.com - Investing.com Canada
TriSalus Life Sciences director Sean Murphy resigns from board - Investing.com India
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Trisalus Life Sciences Inc Stock (TLSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):